Consideration Royalties Sample Clauses

Consideration Royalties. In consideration of the grant in Paragraph 2.1 above, BIOSIGNAL hereby agrees to make the following payments to VANDERBILT: 3.1 Within thirty (30) days of the execution of this Agreement, BIOSIGNAL agrees to pay VANDERBILT within ninety (90) days of the receipt of the MATERIAL by BIOSIGNAL, a 4 of 16 VANDERBILT UNIVERSITY OPTICAL ASSAY AGREEMENT nonrefundable license issue fee of [* * *]. 3.2 BioSignal will pay to Vanderbilt a royalty rate of [* * *] on the Net Sales of LICENSED PRODUCTS and SERVICES from independent third parties, sold by BIOSIGNAL or its sublicensees. 3.3 In order to maintain the exclusive license, beginning one year after first commercial sale of Licensed Products or Services, BIOSIGNAL shall pay to Vanderbilt annual minimum royalties of [* * *] which shall be creditable against earned royalties in the same year for which the minimum is paid. 3.4 BIOSIGNAL shall pay Vanderbilt [* * *] of any up front license fees, other than royalty on sales, received for sublicensing the rights to independent third parties for internal use. 3.5 BioSignal will pay all of the costs incurred in filing for Patent protection of the XXXX technology in the United States (USA) and Canada estimated at fifteen thousand US dollars ($15,000). Vanderbilt shall be provided copies of all official communications, amendments and responses with respect to patent applications and patents sufficiently prior to filing to allow for review, comment and approval by Vanderbilt, which will not be unreasonably withheld. 3.6 All payments required under this agreement shall be in U.S. dollars, and shall be made by check or bank draft and made payable to VANDERBILT. All such payments shall be sent to the following address: Office of Technology Transfer, at 000 00xx Xxxxxx., Xxxxx 000, Xxxxxxxxx Xxxxxxxxx XXX 00000. 3.7 If BIOSIGNAL desires to offer for sale a LICENSED PRODUCT or SERVICE in combination with other of its products and/or services (`COMBINATION PRODUCT" or "COMBINATION SERVICE"), it shall notify VANDERBILT and describe in sufficient detail the nature and composition of the COMBINATION PRODUCT or COMBINATION SERVICE in order that the parties may in good faith determine a reasonable royalty share of such transactions.
Sample 1
AutoNDA by SimpleDocs
Consideration Royalties. At all times, including from and after the Closing, Purchaser or its Affiliates shall retain, pay and discharge as and when due and be responsible for all Liabilities, if any, in respect of, or arising out of (x) ownership of the Consideration Royalties and Consideration Royalty Agreements by Purchaser, its Affiliates or their predecessors in interest prior to the Closing Date, or (y) ownership of the Mineral Properties at any time subject to the Consideration Royalties, including any fixtures and improvements situated thereon, by Purchaser, its Affiliates or their predecessors in interest, and the conduct by Purchaser, its Affiliates or their predecessors in interest of any activity or operation thereon (the “Purchaser Retained Liabilities”).
Sample 1
Consideration Royalties. From and after the Closing, Barrick shall assume and be responsible for the satisfaction, discharge, fulfillment, observance, performance and payment of all Liabilities whatsoever in respect of, or arising out of the ownership of, the Consideration Royalties on or after the Closing Date and the Consideration Royalty Agreements on or after the Closing Date (other than the Purchaser Retained Liabilities).
Sample 1
Consideration Royalties. 7.1 As and for consideration for entering into this Lease, Sterling shall immediately deliver 50,000 shares of Sterling’s restricted common Shares to Xxxxxxx. 7.1.1 On the first anniversary date of this Lease and annually thereafter during the tenor of this Lease, Sterling shall deliver 50,000 Shares of Sterling restricted common Stock to Xxxxxxx. 7.1.2 Xxxxxxx hereby grants to Sterling, during the term of this Lease, an option to purchase up to Two Hundred Thousand (200,000) shares of Chester’s restricted common stock for One Dollar ($1.00) per share. Sterling may exercise this option by providing five (5) days written notice to Xxxxxxx of its intent to purchase. This option shall be exercisable by Sterling for a period of eighteen (18) months form the Effective Date. 7.2 Sterling shall pay the following advance royalties to Xxxxxxx: 7.2.1 Commencing on the Effective Date and monthly thereafter an Advance Royalty of Six Hundred Dollars ($600.00) per month until such time as Net Returns or Net Profits Royalties are payable. 7.2.2 Advance Royalties shall terminate at the time Xxxxxxx commences to receive Net Returns or Net Profit Royalties, as provided in Section 7.3 or Section 7.4, unless such Net Returns or Net Profit Royalty is less that the amount of the Advance Royalty provided for herein, and in that event the Advance Royalty shall be the difference between the Advance Royalty amount and the Net Returns or Net Profit Royalty payable.
Sample 1
Consideration Royalties. In consideration of the non-exclusive license granted herein by Licensor, Licensee shall pay to Licensor: 4.1 Initial Payment: the payment will be in the form of a 51% shareholding in Sprocket HK (Company Number 2208869) to the mutually agreeable corporate memorandum of understanding, to be attached as Exhibit C and made a part hereof.,
Sample 1
Consideration Royalties. 7.1 As and for consideration for entering into this Lease, Sterling shall immediately deliver 30,000 shares of Sterling’s restricted common Shares to Mineral Mountain. 7.1.1 Mineral Mountain hereby grants to Sterling, during the term of this Lease, an option to purchase up to One Million (1,000,000) shares of Mineral Mountain’s restricted common stock for Fifty Cents (.50¢) per share. Sterling may exercise this option by providing five (5) days written notice to Mineral Mountain of its intent to purchase. 7.2 Sterling shall pay the following advance royalties to Mineral Mountain: 7.2.1 Commencing on the Effective Date and annually thereafter an Advance Royalty of Three Thousand Six Hundred Dollars ($3600.00) per year until such time as Net Profits Royalties are payable. 7.2.2 Advance Royalties shall terminate at the time Mineral Mountain commences to receive Net Profit Royalties, as provided in Section 7.3 or Section 7.4, unless such Net Profit Royalty is less that the amount of the Advance Royalty provided for herein, and in that event the Advance Royalty shall be the difference between the Advance Royalty amount and the Net Profit Royalty payable.
Sample 1
Consideration Royalties 
Sample 1Sample 2Sample 3See All (10)
AutoNDA by SimpleDocs

Related to Consideration Royalties

  • Production Royalty When Lessee commences production of ores, minerals or materials from the premises, Lessee shall pay to Lessor a production royalty of 3% of the Net Smelter Returns (NSR) received by Lessee from the sale of said ores, minerals or materials, from the Premises. Lessor may buy out the Lessee’s Production Royalty at a rate of One Million Dollars ($1,000,000.00) per Royalty percentage, with the Lessee retaining One Percent (1%). (1) If Lessee sells refined gold or silver, Lessee will be deemed to have received proceeds from the sale thereof equal to the number of ounces of refined gold or silver outturned to Lessee's account during the calendar quarter multiplied in the case of gold by the average daily London Bullion Brokers P .M Gold Fixing during such calendar quarter and in the case of silver by the average of the daily Engelhard industrial bullion price for silver during the calendar quarter. The average price for a calendar quarter shall be determined by dividing the sum of all daily prices posted during the calendar quarter by the number of days that prices were posted. The posted price shall be obtained from the Wall Street Journal, Reuters, E&MJ or other industry-accepted source. If a posted price referenced above becomes no longer available, Lessee shall, acting reasonably, select an alternative posted price that closely approximates such original posted price. Lessee shall have the right to market and sell to third parties refined gold and silver in any manner it chooses, including the sale of such refined gold and silver on the commodity market. In this regard, Lessor shall have no right to participate in any gains and/or profits or obligation to suffer any losses accruing to Lessee as a result of forward sales, options trading, commodities futures trading or similar transactions. (2) Charges to be deducted from proceeds in determining Net Smelter Returns (a) all costs, charges and expenses paid or incurred by Lessee for treatment in the smelting and refining processes (including handling, processing, interest and provisional settlement fees, sampling, assaying and representation costs, penalties and other processor deductions);

  • Earned Royalties In partial consideration of the License and subject to Sections 3.7 and 3.8, Company will pay to Penn: (i) a graduated royalty as set forth in the table below based upon worldwide annual Net Sales made by Company and its Affiliates (but not sublicensees) of any Designated Compound Sold for use in the Field of Use while covered in the country of Sale of expected use by a Valid Claim of the Assigned BMS Patents that is licensed to Company under the License (but no other Licensed Product): <$500 million [CONFIDENTIAL TREATMENT REQUESTED] /*/% >$500 million but <$750 million [CONFIDENTIAL TREATMENT REQUESTED] /*/% >$750 million but <$1 billion [CONFIDENTIAL TREATMENT REQUESTED] /*/% >$1 billion [CONFIDENTIAL TREATMENT REQUESTED] /*/% [CONFIDENTIAL TREATMENT REQUESTED] /*/ PATENT LICENSE AGREEMENT (ii) a royalty of [CONFIDENTIAL TREATMENT REQUESTED] /*/ percent ([CONFIDENTIAL TREATMENT REQUESTED] /*/%) of Net Sales made by Company and its Affiliates (but not sublicensees) for all Licensed Products that qualify as “Licensed Products” hereunder based on clause (b) of that definition and Sold while covered in the country of Sale of expected use by a Valid Claim of the Penn Existing Patents or Penn New Patents; provided that, notwithstanding any credits provided for in Section 3.7 but subject in all events to Section 3.8, royalties payable by Company for such Net Sales for such Licensed Products shall not be less than [CONFIDENTIAL TREATMENT REQUESTED] /*/ percent ([CONFIDENTIAL TREATMENT REQUESTED] /*/%). Only one royalty shall be due hereunder on the Sale of the same unit of Licensed Product. If a royalty accrues to a Sale of a Licensed Product under both clause (i) and (ii) above, then the higher rate of clause (i) shall apply. Only one royalty shall be due hereunder on the Sale of a Licensed Product even if the manufacture, use, sale, offer for sale or importation of such Licensed Product infringes more than one Valid Claim of the Penn Patent Rights.

  • Consideration Payment 5.1 In consideration of the Company’s Services, the Client shall pay to the Company the Consideration to be stipulated in the Termsheet and all reasonable out of pocket expenses (if any) in accordance with the commercial terms and payment terms as detailed in the Separate Agreement. 5.2 The Company shall send its staff to check for the quality of completion of the Project(s) together with the Client. The Client shall pay for the Company’s Services within 90 days upon the completion of the Project(s) to the satisfaction of the Client. 5.3 The Company shall be entitled to the receivables from the Client for the percentage of Work completed. The date of payment of such Work is stated in the Termsheets and unless the Company is not satisfied with the quality of Work completed and/or the Client has not fulfilled the terms and conditions specified under the Termsheets.

  • Earned Royalty In addition to the annual license maintenance fee, ***** will pay Stanford earned royalties (Y%) on Net Sales as follows:

  • Running Royalties Company shall pay to JHU a running royalty as set forth in Exhibit A, for each LICENSED PRODUCT(S) sold, and for each LICENSED SERVICE(S) provided, by Company or AFFILIATED COMPANIES, based on NET SALES and NET SERVICE REVENUES for the term of this Agreement. Such payments shall be made quarterly. All non-US taxes related to LICENSED PRODUCT(S) or LICENSED SERVICE(S) sold under this Agreement shall be paid by Company and shall not be deducted from royalty or other payments due to JHU. In order to insure JHU the full royalty payments contemplated hereunder, Company agrees that in the event any LICENSED PRODUCT(S) shall be sold to an AFFILIATED COMPANY or SUBLICENSEE(S) or to a corporation, firm or association with which Company shall have any agreement, understanding or arrangement with respect to consideration (such as, among other things, an option to purchase stock or actual stock ownership, or an arrangement involving division of profits or special rebates or allowances) the royalties to be paid hereunder for such LICENSED PRODUCT(S) shall be based upon the greater of: 1) the net selling price (per NET SALES) at which the purchaser of LICENSED PRODUCT(S) resells such product to the end user, 2) the NET SERVICE REVENUES received from using the LICENSED PRODUCT(S) in providing a service, or 3) the net selling price (per NET SALES) of LICENSED PRODUCT(S) paid by the purchaser. No multiple royalties shall be due or payable because any LICENSED PRODUCT(S) or LICENSED SERVICE(S) is covered by more than one claim of the PATENT RIGHTS or by claims of both the PATENT RIGHTS under this Agreement and “PATENT RIGHTS” under any other license agreement between Company and JHU. The royalty shall not be cumulative based on the number of patents or claims covering a product or service, but rather shall be capped at the rate set forth in Exhibit A.

  • Royalty Payments (1) Royalties shall accrue when Licensed Products are invoiced, or if not invoiced, when delivered to a third party or Affiliate. (2) LICENSEE shall pay earned royalties quarterly on or before February 28, May 31, August 31 and November 30 of each calendar year. Each such payment shall be for earned royalties accrued within LICENSEE’s most recently completed calendar quarter. (3) Royalties earned on sales occurring or under sublicense granted pursuant to this Agreement in any country outside the United States shall not be reduced by LICENSEE for any taxes, fees, or other charges imposed by the government of such country on the payment of royalty income, except that all payments made by LICENSEE in fulfillment of UNIVERSITY’s tax liability in any particular country may be credited against earned royalties or fees due UNIVERSITY for that country. LICENSEE shall pay all bank charges resulting from the transfer of such royalty payments. (4) If at any time legal restrictions prevent the prompt remittance of part or all royalties by LICENSEE with respect to any country where a Licensed Product is sold or a sublicense is granted pursuant to this Agreement, LICENSEE shall convert the amount owed to UNIVERSITY into US currency and shall pay UNIVERSITY directly from its US sources of fund for as long as the legal restrictions apply. (5) LICENSEE shall not collect royalties from, or cause to be paid on Licensed Products sold to the account of the US Government or any agency thereof as provided for in the license to the US Government. (6) In the event that any patent or patent claim within Patent Rights is held invalid in a final decision by a patent office from which no appeal or additional patent prosecution has been or can be taken, or by a court of competent jurisdiction and last resort and from which no appeal has or can be taken, all obligation to pay royalties based solely on that patent or claim or any claim patentably indistinct therefrom shall cease as of the date of such final decision. LICENSEE shall not, however, be relieved from paying any royalties that accrued before the date of such final decision, that are based on another patent or claim not involved in such final decision, or that are based on the use of Technology.

  • Minimum Royalties If royalties paid to Licensor do not reach the minimum royalty amounts stated in Section 3.3 of the Patent & Technology License Agreement for the specified periods, Licensee will pay Licensor on or before the Quarterly Payment Deadline for the last Contract Quarter in the stated period an additional amount equal to the difference between the stated minimum royalty amount and the actual royalties paid to Licensor.

  • Sublicense Income Company shall pay Medical School {***} of all Sublicense Income. Such amounts shall be due and payable within sixty (60) days after Company receives the relevant payment from the Sublicensee.

  • Royalties This agreement entitles the author to no royalties or other fees. To such extent as legally permissible, the author waives his or her right to collect royalties relative to the article in respect of any use of the article by the Journal Owner or its sublicensee.

  • Royalty Payment In partial consideration of the grant of rights to Schering by ICN under this Agreement, Schering shall pay ICN a royalty in the following amount: (a) with respect to sales of Product in the EU, [REDACTED] of Net Sales, [REDACTED], but in no event less than [REDACTED] of Net Sales; and (b) with respect to sales of Product in the Territory, other than in the EU: [REDACTED]; [REDACTED]; and [REDACTED]; provided, however, that in no event shall the royalty on sales of the Product in any country in the Territory (including the EU) be less than [REDACTED] per capsule sold based on a [REDACTED], [REDACTED] per capsule sold based on a [REDACTED], and [REDACTED] sold based on a [REDACTED], such amounts to be proportionately adjusted based on a scale of [REDACTED] for other capsule sizes less than [REDACTED] and based on a scale of [REDACTED] for other capsule sizes in excess of [REDACTED]; provided further, however, that if in any country in the Territory ICN is also marketing the Product, and if at any time ICN's current actual net selling price for the Product is less than [REDACTED] of Schering's current actual net selling price for the Product (based on the same capsule size and comparable terms and conditions, and other than due to increases in price by Schering), then such minimum royalty shall no longer apply to sales of the Product by Schering in such country (and such minimum royalty shall not be reinstated). In the event any third party is also marketing oral ribavirin in any country in the Territory, then Schering shall not be obligated to pay the minimum royalty provided for in this Section 6.2 for that country. [REDACTED] For purposes of this Section 6.2, the current actual net selling price shall be determined on a country-by-country basis, for each calendar quarter, by dividing the Net Sales of capsules of a particular capsule strength by the total number of capsules of the same strength that were sold and sampled in such country during such period. Each Party shall have the right to audit the books and records of the other Party for the purpose of verifying the current actual net selling price, in accordance with the procedures set forth in Section 6.10.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!